When the coronavirus pandemic began, the challenge for Pfizer and BioNTech wasn't just developing a Covid-19 vaccine -- they also had to make it, and by the hundreds of millions.
April 01, 2021 at 07:52AM https://ift.tt/3dt8dZv the coronavirus pandemic began, the challenge for Pfizer and BioNTech wasn't just developing a Covid-19 vaccine -- they also had to make it, and by the hundreds of millions.